DNASequence is a biotechnology company and provider of innovative techniques for pathogen identification, microbiome characterization, environmental monitoring and more. The team is comprised of seasoned professionals with expertise in biotechnology, bioinformatics and software solutions.
With deep expertise in metagenomic analysis, the company aims to promote sustainable development in critical sectors such as health, agricultural production, biosafety, and the food industry. Its approach is interdisciplinary, integrating biotechnology, bioinformatics, metagenomics analysis, artificial intelligence and modern digital tools to efficiently manage large datasets.
STATE-OF-THE-ART
Laboratory & infrastruction
DNA Sequence SRL operates a fully equipped, state-of-the-art laboratory featuring cutting-edge equipment for DNA and RNA analysis, as well as the identification of microbial species and pathogens. The Next Generation Sequencing (NGS) platforms utilized by the company enable it to analyze large volumes of data with high precision and speed, ensuring the reliability of results and the integrity of the data.
Our cutting-edge laboratory in Thessaloniki is one of the few in the industry accredited with ISO 17025 in metagenomic analysis. Our primary focus is the analysis of environmental samples—such as soil, surfaces, drinking water, wastewater, clinical samples and air—where we have both the expertise and capability to manage all project stages, from sampling to delivering a final report of findings.
OboroBio: Smart Multi-Omics for Everyone
OboroBio is DNA Sequence’s next-generation, cloud-based platform designed to simplify and accelerate the interpretation of omics data. Built on a robust technological infrastructure, it integrates advanced bioinformatics algorithms with AI-powered automation to process and analyze raw NGS-derived datasets—without requiring specialized expertise from the end user.
Developed for accessibility and performance, OboroBio leverages a patented system, “Method and System for the Automated Evaluation of Biological Data” (OBI No. 1010503), to deliver high-accuracy results with exceptional efficiency. By replacing traditional, manual bioinformatics workflows with an intelligent, automated pipeline, the platform ensures faster turnaround times, greater consistency, and deeper insights.
This agentic approach empowers professionals across healthcare, environmental science, and biotechnology to gain actionable insights—regardless of their background in data analysis. The platform is also backed by ISO 27001 certification, ensuring robust information security and compliance across all use cases.
